EDGAR Filing Documents for 0001144204-18-045149

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-18-045149

Filing Date

2018-08-16

Accepted

2018-08-16 16:15:25

Documents

Period of Report

2018-08-16

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	tv500938_6k.htm	6-K	12398
2	EXHIBIT 99.1	tv500938_ex99-1.htm	EX-99.1	202337
3	EXHIBIT 99.2	tv500938_ex99-2.htm	EX-99.2	41567
	Complete submission text file	0001144204-18-045149.txt		257501

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 181023493
SIC: 2834 Pharmaceutical Preparations